GeneNews appoints strategic advisor for product launch
This article was originally published in Scrip
Executive Summary
GeneNews (Canada), a developer of blood-based biomarker tests for the early detection of diseases, has appointed Patrick Terry lead strategic advisor for the US commercial launch of its blood-base colorectal cancer risk test, ColonSentry. Mr Terry was co-founder of Genomic Health, and former director of consumer advocacy and governmental affairs at the company. He will help lead the launch of ColonSentry in the US next year.